University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Chris Keh, M.D.

Infectious disease specialist

Dr. Chris Keh is a specialist in the Infectious Diseases Clinic at UCSF Medical Center, where she treats patients with general infectious diseases.

Keh earned undergraduate and medical degrees at the University of Illinois at Chicago before completing an internal medicine residency at the University of Chicago Medical Center. She completed an infectious diseases fellowship at UCSF Medical Center, where she is an assistant professor of medicine and infectious diseases. She currently serves as the medical director at the San Francisco Department of Public Health's tuberculosis clinic.


Infectious Disease at Parnassus
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0327
Phone: (415) 353-2626
Fax: (415) 353-2568

Hours: Thursday
8:20 – 11:40 a.m.

More about Chris Keh


University of Illinois School of Medicine 2004


University of Chicago Medical Center, Internal Medicine 2008


UCSF Medical Center, Infectious Diseases 2010

Selected Research and Publications

  1. Greninger AL, Langelier C, Cunningham G, Keh C, Melgar M, Chiu CY, Miller S. Two Rapidly Growing Mycobacterial Species Isolated from a Brain Abscess: First Whole-Genome Sequences of Mycobacterium immunogenum and Mycobacterium llatzerense. J Clin Microbiol. 2015 Jul; 53(7):2374-7.
  2. Eriksson EM, Liegler T, Keh CE, Karlsson AC, Holditch SJ, Pilcher CD, Loeb L, Nixon DF, Hecht FM. Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences. PLoS One. 2014; 10(4):e0120787.
  3. Kelly JD, Grace Lin SY, Barry PM, Keh C, Higashi J, Metcalfe JZ. Xpert MTB/RIF False Detection of Rifampin-Resistant Tuberculosis from Prior Infection. Am J Respir Crit Care Med. 2014 Dec 1; 190(11):1316-8.
  4. Keh CE, Jha AR, Nzarubara B, Lanar DE, Dutta S, Theisen M, Rosenthal PJ, Dorsey G, Nixon DF, Greenhouse B. Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda. PLoS One. 2012; 7(12):e52571.
  5. Eriksson EM, Keh CE, Deeks SG, Martin JN, Hecht FM, Nixon DF. Differential expression of CD96 surface molecule represents CD8? T cells with dissimilar effector function during HIV-1 infection. PLoS One. 2012; 7(12):e51696.
  6. Eriksson EM, Milush JM, Ho EL, Batista MD, Holditch SJ, Keh CE, Norris PJ, Keating SM, Deeks SG, Hunt PW, Martin JN, Rosenberg MG, Hecht FM, Nixon DF. Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity. Blood. 2012 Jan 19; 119(3):745-55.
  7. Laiteerapong N, Keh CE, Naylor KB, Yang VL, Vinci LM, Oyler JL, Arora VM. A resident-led quality improvement initiative to improve obesity screening. Am J Med Qual. 2011 Jul-Aug; 26(4):315-22.
  8. Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis. 2010 Apr 1; 50(7):e47-9.
  9. Porter BO, Anthony KB, Shen J, Hahn B, Keh CE, Maldarelli F, Blackwelder WC, Lane HC, Kovacs JA, Davey RT, Sereti I. Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial. AIDS. 2009 Jan 14; 23(2):203-12.
  10. Keh CE, Shen JM, Hahn B, Hallahan CW, Rehm CA, Thaker V, Wynne SM, Davey RT, Lane HC, Sereti I. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients. AIDS. 2006 Feb 14; 20(3):361-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.